Jpmorgan Chase & Co »

Ligand Pharmaceuticals In shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $191k 12k 15.38
2010-12-31 $167k 19k 8.94

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Congress Asset Management
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Ubs Global Asset Management Americas

View all funds holding Ligand Pharmaceuticals In